Publications
Academic article
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen et al. (2022). Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment. (external link)
- Mads Malm Svenningsson; Gard Frodahl Tveitevåg Svingen; Vegard Lysne et al. (2020). Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. (external link)
- Mary Priyanka Udumula; Mangali Suresh Babu; Audesh Bhat et al. (2017). High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells. (external link)
- Mika Hilvo; Indu Dhar; Mitja Lääperi et al. (2021). Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts. (external link)
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Thomas Olsen et al. (2021). β-blocker use and risk of all-cause mortality in patients with coronary heart disease: effect modification by serum vitamin A. (external link)
- Kamila Borowczyk; Justyna Piechocka; Rafał Głowacki et al. (2018). Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial. (external link)
- Arti Dhar; Mary Priyanka Udumula; Brahmam Medapi et al. (2016). Pharmacological evaluation of novel alagebrium analogs as methylglyoxal scavengers in vitro in cardiac myocytes and in vivo in SD rats. (external link)
- Anthea Van Parys; Vegard Lysne; Gard Frodahl Tveitevåg Svingen et al. (2019). Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris. (external link)
- Indu Dhar; Vegard Lysne; Gard Frodahl Tveitevåg Svingen et al. (2019). Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. (external link)
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Per Magne Ueland et al. (2018). Plasma cystathionine and risk of incident stroke in patients with suspected stable angina pectoris. (external link)
- Espen Øglænd Bjørnestad; Hilde Olset; Indu Dhar et al. (2020). Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. (external link)
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen et al. (2018). Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease: Results from two independent cohorts. (external link)
- Barbara N. DeRatt; Maria A. Ralat; Vegard Lysne et al. (2017). Metabolomic evaluation of the consequences of plasma cystathionine elevation in adults with stable angina pectoris. (external link)
- Suresh Babu Mangali; Audesh Bhat; Mary Priyanka Udumula et al. (2018). Inhibition of protein kinase R protects against palmitic acid?induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes. (external link)
- Marianne Bråtveit; Anthea van Parys; Thomas Olsen et al. (2024). Association between dietary macronutrient composition and plasma one-carbon metabolites and B-vitamin cofactors in patients with stable angina pectoris. (external link)
- Mads Malm Svenningsson; Gard Frodahl Tveitevåg Svingen; Per Magne Ueland et al. (2025). Elevated plasma trimethyllysine is associated with incident atrial fibrillation. (external link)
- M Hilvo; PJ Meikle; Eva Ringdal Pedersen et al. (2019). Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.. (external link)
- Espen Øglænd Bjørnestad; Indu Dhar; Gard Frodahl Tveitevåg Svingen et al. (2021). Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease. (external link)
- Indu Dhar; Sumia Siddique; Eva Kristine Ringdal Pedersen et al. (2020). Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. (external link)
- Thomas Olsen; Kathrine Vinknes; Rune Blomhoff et al. (2019). Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. (external link)
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Arve Ulvik et al. (2025). Serum Vitamin A Is Associated with Variations in the Relationship between Plasma B6 Vitamers and Cardiovascular Disease Risk. (external link)
- Indu Dhar; Gard Frodahl Tveitevåg Svingen; Espen Øglænd Bjørnestad et al. (2023). B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study. (external link)
- Indu Dhar; Vegard Lysne; Reinhard Seifert et al. (2018). Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors. (external link)
- Mary Priyanka Udumula; Audesh Bhat; Suresh Babu Mangali et al. (2018). Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats. (external link)
- Thomas Olsen; Kathrine Vinknes; Gard Frodahl Tveitevåg Svingen et al. (2018). The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A. (external link)
- Jaspreet Kalra; Suresh Babu Mangali; Audesh Bhat et al. (2018). Imoxin attenuates high fructose-induced oxidative stress and apoptosis in renal epithelial cells via downregulation of protein kinase R pathway. (external link)
- Indu Dhar; Vegard Lysne; Arve Ulvik et al. (2023). Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study. (external link)
- Gard Frodahl Tveitevåg Svingen; Hui Zuo; Per Magne Ueland et al. (2018). Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. (external link)
- Espen Øglænd Bjørnestad; Indu Dhar; Gard Frodahl Tveitevåg Svingen et al. (2022). Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. (external link)